Litigation by the Alaska Personal Injury Law Group has been cited in the Journal of Clinical Pharmacology & Therapeutics for its role in aiding the FDA in its decision to finally rule that ephedra products were adulterated under the Federal Food, Drug, and Cosmetic Act. The litigation, Talbert v. E’ola Products, Inc., 3AN-97-4046, was handled by Richard E. Vollertsen and arose out of stroke injuries suffered by a young woman using an ephedra weight loss product that had also been spiked with ephedrine hydrochloride.
“Clinical Pharmacology and Dietary Supplements: An Evolving Relationship,” Clinical Pharmacology & Therapeutics, Vol. 87, No. 2, Feb. 2010.